Daily Step Counts Reveal Frailty Trajectories in Lung Cancer Patients During Radiotherapy

A new prospective longitudinal study of 327 patients with lung cancer undergoing radiotherapy has found that something as ordinary as a daily step count, captured silently by a smartphone app, can reveal which patients are likely to slip into worsening frailty during treatment. The research, led by Jiang Zhang, Jiang Wu, Song Li, and colleagues at Yunnan Cancer Hospital and the Nursing School of Kunming Medical University, and published in the Journal of Cancer Survivorship, tracked frailty before radiotherapy, at the end of treatment, and one month afterward, while continuously collecting daily walking data through the WeChat Step Mini-program. The results suggest that low-cost, real-world movement monitoring could become a powerful early warning system for one of the most dangerous syndromes in cancer care.

Frailty, long recognized in geriatric medicine, is a state of diminished physiological reserve in which relatively minor stressors, such as a course of radiation, can trigger disproportionate declines in health. Prior research, including a systematic review and meta-analysis published in Chest in 2022, has shown that frailty is common among patients with lung cancer and is linked to poorer treatment tolerance, more complications, and higher mortality. What has been missing is a way to capture frailty not as a single snapshot but as a dynamic process unfolding over the weeks of treatment, when the body is being pushed hardest by daily radiation fractions.

To capture that dynamism, the research team turned to latent class growth modeling, a statistical technique that sorts individuals into unobserved subgroups based on how their measurements change over time. Rather than assuming that all patients respond to radiotherapy in the same way, the method lets the data reveal distinct patterns of decline, stability, or recovery. Applied to frailty scores measured with the Frailty Phenotype Scale, originally developed by Fried and colleagues in 2001 and based on indicators such as unintentional weight loss, exhaustion, weakness, slow walking speed, and low physical activity, the model uncovered three clearly separable trajectories within the cohort.

The largest group, accounting for 56.58 percent of patients, followed a pattern the researchers labeled prefrailty declining: these patients started treatment in a prefrail state and became progressively frailer as radiotherapy proceeded. A second group, 27.83 percent of the cohort, showed a frailty stable increasing trajectory, beginning already frail and worsening further over the treatment course. The smallest but most concerning group, 15.60 percent, followed a severe frailty increasing trajectory, starting from severe frailty and deteriorating still more. The heterogeneity is striking: patients who looked superficially similar at the start of treatment diverged onto markedly different health paths over just a few weeks.

The central question of the study was whether objectively measured daily activity could distinguish these trajectories. Every patient’s steps were recorded from the first day of radiotherapy to the last, producing a continuous, ecologically valid record of physical behavior during a period when patients are often too exhausted or ill to maintain structured exercise. This approach sidesteps a well-known weakness of self-reported activity questionnaires, which are vulnerable to recall bias and social desirability, and instead leverages the ubiquitous smartphone as a passive sensor. Validation studies, including work published in Frontiers in Public Health, have shown that smartphone-based step counting such as the WeRun platform compares reasonably well with research-grade accelerometers in free-living conditions.

The answer was clear. After adjustment for demographic and clinical covariates, higher average daily step counts during radiotherapy were independently associated with a lower likelihood of belonging to the adverse frailty trajectories. Patients who moved more were substantially less likely to land in the stable increasing or severe increasing frailty groups, even after accounting for factors such as age and clinical characteristics that might otherwise explain the relationship. While the observational design cannot prove that walking itself protects against frailty, the association held firm in multivariable analysis, suggesting that daily ambulation is a meaningful behavioral marker of physiological resilience during cancer treatment.

Perhaps the most practically interesting finding is that the association was not linear. Instead, the researchers observed step-count gradients at approximately 3,000, 6,000, and 9,000 steps per day, which they interpret as exploratory thresholds delimiting different frailty-risk intervals. Patients averaging below these levels faced progressively higher odds of adverse trajectories. If confirmed in future research, such thresholds could give clinicians simple, interpretable targets, much as 10,000 steps per day has entered popular health culture, but here grounded in a specific vulnerable population and a specific treatment window rather than in the general public.

The clinical implications extend beyond measurement. Radiotherapy for lung cancer is increasingly delivered with curative intent, and interventions such as pulmonary rehabilitation during treatment have already been tested in randomized trials, with a 2025 study in Lung Cancer reporting clinical benefit. Continuous step monitoring could identify, in near real time, which patients are becoming sedentary and therefore likely to be traveling down an adverse frailty path, allowing clinicians to intervene with tailored exercise prescriptions, nutritional support, or geriatric assessment before irreversible decline occurs. The authors argue that combining continuous step data with routine frailty screening could support early identification of high-risk patients and proactive, individualized management during and after radiotherapy.

The study also demonstrates how consumer mobile health technology can transform cancer supportive care research, particularly in settings where dedicated wearable devices are impractical. The research was supported by the Scientific Research Fund of the Yunnan Provincial Department of Education, the Research Fund of the Chinese Nursing Association, and other provincial and institutional funds, and the authors note that sponsors had no role in the design or interpretation of the study. As the global burden of lung cancer continues to grow, with GLOBOCAN 2024 estimates documenting rising incidence worldwide, scalable tools that convert everyday behavior into actionable clinical intelligence may prove essential. A phone in the pocket, quietly counting steps, could become one of the simplest yet most informative instruments in the oncology clinic.

Subject of Research: Association between daily step counts and frailty trajectory classes in lung cancer patients undergoing radiotherapy

Article Title: Association between daily step counts and frailty trajectory classes in lung cancer patients undergoing radiotherapy: a prospective longitudinal study

Article References: Zhang, J., Wu, J., Li, S., Wu, X., Ran, L., & Zhao, X. (2026). Association between daily step counts and frailty trajectory classes in lung cancer patients undergoing radiotherapy: a prospective longitudinal study. Journal of Cancer Survivorship. https://doi.org/10.1007/s11764-026-02117-y

Image Credits: AI Generated

DOI: 10.1007/s11764-026-02117-y

Keywords: lung cancer, radiotherapy, frailty, daily step count, latent class growth model, longitudinal study, cancer survivors, physical activity, mobile health, radiation oncology, Association, between